FindTrial
Sign In

Ketogenic Diet for the Treatment of Drug-resistant Epilepsy and Cognitive Impairment Associated with Tuberous Sclerosis Complex

Ketogenic Diet for the Treatment of Drug-resistant Epilepsy and Cognitive Impairment Associated with Tuberous Sclerosis Complex

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047909
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-07-15
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-resistant Epilepsy and Cognitive Impairment Associated with Tuberous Sclerosis Complex

Interventions

case series:ketogenic diet

Sponsors

Shenzhen Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. In line with the TSC diagnostic criteria revised by the International TSC Alliance in 2012; 2. After regular treatment with 2 or more anti-epileptic drugs, the seizure-free state still cannot be achieved or there is still abnormal EEG discharge or mental and motor development retardation; 3. Received KD treatment, and the treatment and follow-up time of KD is more than 1 month.

Exclusion criteria

Exclusion criteria: 1. Patients with serious diseases of vital organs; 2. Parents who cannot cooperate; 3. Patients with serious missing medical records.

Design outcomes

Primary

MeasureTime frame
seizure frequency;cognitive and behavioral status;—

Countries

China

Contacts

Public ContactLiao Jianxiang

Shenzhen Children's Hospital

liaojianxiang@vip.sina.com+86 18938691168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026